Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-011948

Chief Scientific Officer sold 7,400 shares at an average $33.46 ($247,578)

  • Chief Scientific Officer acquired 7,400 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2020-02-20 Option exercise +7,400 $6.32 $46,768 78,079 D
ROBINS HARLAN S Chief Scientific Officer 2020-02-20 Sale −800 $32.85 $26,280 77,279 D
ROBINS HARLAN S Chief Scientific Officer 2020-02-20 Sale −6,600 $33.53 $221,298 70,679 D
Derivatives
ROBINS HARLAN S Chief Scientific Officer 2020-02-20 Option exercise · Stock Option (Right to Buy) −7,400 555,600 D
Open-market sales · 7,400 sh · avg $33.46 · $247,578
Loading xslF345X03/doc4.xml…